this post was submitted on 23 Jan 2024
465 points (86.8% liked)
Microblog Memes
5494 readers
2042 users here now
A place to share screenshots of Microblog posts, whether from Mastodon, tumblr, ~~Twitter~~ X, KBin, Threads or elsewhere.
Created as an evolution of White People Twitter and other tweet-capture subreddits.
Rules:
- Please put at least one word relevant to the post in the post title.
- Be nice.
- No advertising, brand promotion or guerilla marketing.
- Posters are encouraged to link to the toot or tweet etc in the description of posts.
Related communities:
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
We're talking about glioblastoma here, there's not much "continous" treatment to be had and temozolomide's and bevacizumab's patents have run out (edit: also bevacizumab doesn't prolong overall survival at all and temozolomide is ineffective in MGMT-positive patients, i.e. about half).
That said, I'm not sure why the other commenter is so dismissive of your idea. There's plenty of drugs that have been kept in the cupboard (e.g. desloratadine) or not seeking approval for certain illnesses so a "new", more expensive drug could be sold (e.g. no rituximab trials for multiple sclerosis so Roche could sell Ocrelizumab, no Bevacizumab trials for macular degeneration so they could sell Ranibizumab) โ and certainly many more that we never heard about.